ATP5C1 (ATP synthase subunit gamma, mitochondrial) is a nuclear-encoded gene located on human chromosome 10 (10p15.1) . It encodes the gamma subunit of mitochondrial ATP synthase (Complex V), a critical enzyme for ATP production during oxidative phosphorylation . This enzyme catalyzes ATP synthesis by harnessing the proton gradient across the mitochondrial inner membrane .
Transcript Variants: Alternative splicing produces tissue-specific isoforms, including liver (L) and heart (H) variants differing by a single amino acid (Asp273) .
The gamma subunit is part of the F₁ catalytic domain of ATP synthase, which includes α, β, γ, δ, and ε subunits . Its structure includes:
Isoforms: Liver (L) and heart (H) variants differ in C-terminal residues, influencing enzyme activity .
Subunit | Role | Stoichiometry |
---|---|---|
α (ATP5A1) | Catalytic core | 3 copies |
β (ATP5B) | Catalytic core | 3 copies |
γ (ATP5C1) | Central stalk | 1 copy |
δ (ATP5D) | Peripheral stalk | 1 copy |
ε (ATP5E) | Regulatory | 1 copy |
ATP5C1 is ubiquitously expressed but shows elevated activity in energy-demanding tissues:
ATP5C1 facilitates rotary catalysis by coupling proton translocation (via the F₀ subunit) to ATP synthesis . Mutations in ATP synthase subunits (e.g., δ subunit) disrupt assembly, reducing ATP production and mitochondrial cristae density .
While ATP5C1-specific mutations are not yet linked to human diseases, ATP synthase deficiencies are implicated in:
Mitochondrial Disorders: Complex V deficiency, Batten disease, and neurodegeneration .
Mechanisms: Impaired subunit assembly, altered proton channel activity, or c-ring aggregation .
Disease | Subunit Affected | Pathological Features |
---|---|---|
Complex V Deficiency | δ, a, c | Reduced ATP synthesis, mitochondrial dysfunction |
Batten Disease | c-subunit | Lysosomal accumulation, neurodegeneration |
Hypertrophic Cardiomyopathy | GTPBP3 | tRNA metabolism defects, ATP synthase dysfunction |
The c-subunit of F₀ forms a voltage-gated ion channel (ACLC), which is inhibited by F₁ binding . Dissociation of F₁ from F₀ during stress (e.g., glutamate toxicity) triggers mitochondrial permeability transition .
Recombinant ATP5C1: Expressed in E. coli (His-tagged, 26–298 aa), used in SDS-PAGE and Western blot .
Antibodies: Monoclonal (e.g., 60284-1-Ig) validated for WB, IHC, and flow cytometry .
ATP5C1 is classified as Amber in mitochondrial disorder panels due to insufficient evidence linking mutations to disease .
ATP5C1 (ATP synthase F1 subunit gamma) is an essential component of the mitochondrial ATP synthase complex that plays a critical role in oxidative phosphorylation. It functions as part of the central rotor shaft within the F1 catalytic domain, facilitating the conversion of ADP to ATP using the proton gradient established across the inner mitochondrial membrane. Recent genome-wide RNA-interactome studies have identified ATP5C1 as a RNA-binding protein (RBP) across various eukaryotes, including humans .
ATP5C1 is encoded by the nuclear genome, synthesized as a precursor protein in the cytosol, and subsequently imported into mitochondria where it assembles into the functional ATP synthase complex. Similar to other F1-ATP synthase subunits like ATP5A1 and ATP5B, ATP5C1 has been found to interact with cellular RNAs, which may play regulatory roles in its mitochondrial import process.
When investigating ATP5C1's RNA-binding capabilities, researchers should implement a comprehensive approach:
Target Identification:
Binding Characterization:
Functional Validation:
Subcellular Localization:
This methodical approach ensures comprehensive characterization of ATP5C1's RNA-binding capabilities while maintaining experimental rigor.
Based on current research approaches, several experimental models have proven effective for studying different aspects of ATP5C1 biology:
Model System | Applications | Advantages | Limitations |
---|---|---|---|
Human hepatoma cell lines (e.g., Huh7) | RNA binding studies, protein localization | Well-characterized, amenable to genetic manipulation | May not represent tissue-specific functions |
Inducible expression systems | Structure-function analysis | Controlled expression of wild-type and mutant proteins | Potential artifacts from overexpression |
Isolated mitochondria | Import assays | Direct assessment of ATP5C1 import kinetics | Limited timeframe for experiments |
Recombinant protein systems | Biochemical assays, structural studies | Allows precise manipulation of protein sequence | Lacks cellular context |
Patient-derived cells | Disease-relevant studies | Captures pathological context | Genetic variability between samples |
When selecting an experimental model, researchers should consider the specific aspect of ATP5C1 biology under investigation. For example, studies of RNA-binding properties and mitochondrial import may benefit from cellular systems that maintain the native cytosolic-mitochondrial interface, while structural studies might require purified recombinant proteins .
While comprehensive characterization of ATP5C1's RNA interactome is still emerging, comparative analyses with other ATP synthase subunits reveal distinct binding profiles:
ATP5C1 exhibits RNA-binding properties that appear distinct from ATP5A1, another subunit of the F1-ATP synthase complex. eCLIP-Seq analysis has demonstrated that ATP5C1 binds to RNA regions that differ from those bound by ATP5A1 . This suggests specialized functions in RNA metabolism despite belonging to the same protein complex.
ATP5A1, by comparison, has been extensively characterized:
Binds predominantly to cytosolic mRNAs (~86% of targets)
Recognizes distinct sequence motifs: a ~10-nucleotide polypyrimidine (CU) motif in 5'UTRs and a ~20-nucleotide G-rich motif in 3'UTRs/CDS regions
Shows enrichment for mRNAs involved in translation, particularly those containing TOP motifs
More detailed comparative studies are needed to fully elucidate ATP5C1's binding preferences and target specificity, which could reveal functional specialization among ATP synthase subunits in RNA metabolism.
When studying ATP5C1's potential role in mitochondrial import, researchers should implement a multi-faceted experimental approach incorporating principles of true experimental design:
Generate labeled ATP5C1 precursor using in vitro translation with 35S-methionine
Isolate human mitochondria and divide into treatment groups:
RNase-treated vs. mock-treated controls
Membrane potential-dissipated vs. intact controls
Monitor import and processing by gel electrophoresis over a time course (typically 10 minutes)
Include control proteins (e.g., ornithine transcarbamylase) to demonstrate specificity
Create constructs with varied mitochondrial targeting signals (MTS):
Wild-type MTS (wtMTS)
Engineered MTS (eMTS) with integrated tags
MTS-deleted controls (noMTS)
Develop RNA-binding deficient mutants in these backgrounds
Monitor localization using confocal microscopy
This comprehensive approach follows true experimental design principles by incorporating:
Randomization of samples
Multiple control conditions
Statistical analysis of results using repeated measures ANOVA with appropriate post-hoc tests
Based on successful approaches with similar proteins such as ATP5A1, researchers can employ the following strategy to create and validate RNA-binding deficient mutants of ATP5C1:
Analyze protein structure using tools like AlphaFold2
Identify surface-exposed, positively charged residues (Arg, Lys) likely to interact with RNA
Create multiple mutants targeting different regions:
Single mutations for targeted analysis
Combined mutations for stronger effect
Focus on residues outside known functional domains
Validation Parameter | Methodology | Expected Outcome |
---|---|---|
RNA binding | RIP-qPCR with specific target RNAs | Significant reduction in RNA enrichment compared to wild-type |
Protein folding | Circular dichroism spectroscopy | Similar secondary structure profile to wild-type |
Complex assembly | Co-immunoprecipitation with partner proteins | Maintained interaction with ATP5A1, ATP5B, and ATP5F1 |
Subcellular localization | Confocal microscopy with mitochondrial co-stain | Proper mitochondrial localization |
Functional integrity | Seahorse respirometry | Comparable oxygen consumption rate when replacing endogenous protein |
Compare import kinetics between wild-type and mutant proteins
Monitor ATP production capacity
Assess impact on cellular respiration and mitochondrial membrane potential
This systematic approach ensures that any phenotypes observed can be specifically attributed to disrupted RNA binding rather than to general protein dysfunction or misfolding .
For robust analysis of ATP5C1 eCLIP-Seq data, researchers should implement a comprehensive statistical framework:
Quality Control:
Filter low-quality reads (PHRED score < 20)
Remove PCR duplicates using unique molecular identifiers
Trim adapters and barcode sequences
Alignment:
Map to reference genome using splice-aware aligners (STAR, HISAT2)
Filter multi-mapping reads
Peak Calling:
This comprehensive analytical approach ensures reliable identification of ATP5C1's RNA interactome while minimizing false positives and enabling biological interpretation of binding patterns.
When investigating ATP5C1-RNA interactions, comprehensive controls are essential to ensure specificity and reliability of findings:
Implement true experimental designs with randomization when possible
Consider Solomon four-group design to control for testing effects in cellular studies
Include at least three biological replicates for statistical power
Perform blinded analysis of imaging data to prevent bias
These comprehensive controls are critical for distinguishing genuine ATP5C1-RNA interactions from experimental artifacts and for ensuring reproducibility across different experimental conditions.
To assess the functional impact of ATP5C1's RNA interactions, researchers should employ a multi-parameter approach that examines several aspects of ATP5C1 and mitochondrial biology:
Compare import kinetics between wild-type and RNA-binding deficient mutants
Conduct in vitro import assays with and without RNase treatment
Measure the ratio of processed (mature) to unprocessed (precursor) protein over time
Quantify import efficiency under various cellular stress conditions
Parameter | Methodology | Expected Outcome if RNA Binding is Functional |
---|---|---|
Complex assembly | Blue native PAGE | Reduced assembly in RNA-binding mutants |
ATP production | Luminescence-based ATP assays | Decreased ATP synthesis capacity |
Proton pumping | ACMA fluorescence quenching | Altered proton translocation efficiency |
Enzyme activity | ATPase activity assays | Reduced enzymatic function |
Measure oxygen consumption rate (OCR) using Seahorse respirometry
Compare baseline, ATP-linked, and maximal respiration
Assess mitochondrial membrane potential using fluorescent probes
Evaluate metabolic flexibility through substrate utilization studies
Monitor cell growth and proliferation
Assess resistance to metabolic stress
Measure reactive oxygen species production
Evaluate mitochondrial dynamics (fusion/fission)
Rigorous antibody validation is crucial for reliable ATP5C1 research, particularly for techniques like immunoprecipitation and eCLIP-seq. Researchers should implement the following comprehensive validation protocol:
Specificity Testing:
Western blot analysis comparing wild-type and ATP5C1 knockdown samples
Probing multiple cell lines to confirm consistent detection
Testing with recombinant ATP5C1 as positive control
Evaluating cross-reactivity with other ATP synthase subunits
Application-Specific Validation:
Application | Validation Method | Acceptance Criteria |
---|---|---|
Immunoblotting | Serial dilution analysis | Single band at expected MW, linear signal response |
Immunoprecipitation | Mass spectrometry of pulldown | ATP5C1 as top hit, enrichment of known interactors |
Immunofluorescence | Colocalization with mitochondrial markers | >90% overlap with mitochondrial staining |
Comparison with second ATP5C1 antibody | Concordant staining pattern | |
eCLIP-seq | Mock IP control comparison | >10-fold enrichment over mock IP |
Testing with RNA-binding deficient mutants | Reduced signal with mutants |
Reporting Standards:
Document antibody source, catalog number, lot number, and dilution
Report validation results including positive and negative controls
Archive validation data for reference
Thorough antibody validation is essential as it directly impacts the reliability of downstream analyses. For eCLIP-seq experiments, antibody specificity is particularly critical as non-specific binding can lead to false identification of RNA targets .
The RNA-binding capacity of ATP5C1 may represent a previously unrecognized regulatory mechanism affecting mitochondrial function through several potential pathways:
Regulated Mitochondrial Import:
Similar to ATP5A1, ATP5C1's RNA interactions may facilitate its import into mitochondria. Studies with ATP5A1 have demonstrated that RNA promotes mitochondrial import both in vitro and in cellulo . Given that ATP5C1 belongs to the same complex, it may share this regulatory mechanism.
Coordinated Complex Assembly:
RNA binding might synchronize the import and assembly of different ATP synthase subunits, ensuring stoichiometric assembly of the complex. This would be particularly important during increased energy demands when coordinated upregulation of all subunits is necessary.
Response to Cellular Stress:
RNA interactions could modulate ATP5C1 import in response to various cellular stresses, providing a rapid mechanism to adjust mitochondrial ATP production capacity without requiring transcriptional changes.
Cross-talk with Cytosolic Translation:
The observation that ATP5A1 binds mRNAs involved in translation, particularly those with TOP motifs , suggests these interactions might coordinate energy production with translational activity—a major consumer of cellular ATP.
RNase treatment significantly reduces ATP5A1 import rate in isolated mitochondria
ATP5A1 interacts with RNAs at the outer mitochondrial membrane
RNA-binding deficient mutants of ATP5A1 show altered import dynamics
Understanding ATP5C1's RNA-binding function could reveal new regulatory mechanisms governing mitochondrial bioenergetics and provide insights into diseases characterized by mitochondrial dysfunction.
ATP5C1 research has significant implications for understanding various human diseases, particularly those involving mitochondrial dysfunction:
Analyze ATP5C1 expression, localization, and RNA-binding in patient-derived samples
Examine genetic variants affecting ATP5C1's RNA-binding capacity
Develop therapeutic approaches targeting ATP5C1-RNA interactions
Explore ATP5C1 as a biomarker for mitochondrial dysfunction
Understanding the relationship between ATP5C1's RNA-binding properties and disease pathogenesis could open new avenues for diagnostic and therapeutic interventions targeting mitochondrial function in various pathological conditions .
Several cutting-edge technologies hold promise for advancing ATP5C1 research:
Technology | Application to ATP5C1 Research | Potential Insights |
---|---|---|
Cryo-Electron Microscopy | - Visualize ATP5C1-RNA complexes - Determine binding interfaces - Study conformational changes | Structural basis of RNA recognition and its impact on protein conformation |
Single-Molecule Techniques | - FRET analysis of ATP5C1-RNA interactions - Optical tweezers to measure binding kinetics - Super-resolution imaging of import process | Real-time dynamics of RNA binding and its effect on mitochondrial import |
CRISPR-Based Technologies | - Base editing for precise mutagenesis - CRISPRi/CRISPRa for expression modulation - Prime editing for specific mutations | Functional consequences of specific RNA-binding domains or motifs |
Spatial Transcriptomics | - Map ATP5C1-RNA interactions in situ - Correlate with mitochondrial distribution - Analyze cell type-specific patterns | Spatial organization of interactions and their relationship to mitochondrial networks |
Microfluidics and Organ-on-Chip | - High-throughput screening of RNA ligands - Real-time monitoring of import kinetics - Analysis in physiologically relevant systems | Identification of optimal RNA partners and physiological relevance |
These technologies should be implemented within rigorous experimental frameworks, including:
Appropriate control conditions
Multiple biological replicates
Blinded analysis of results
By combining these advanced technologies with sound experimental design principles, researchers can gain unprecedented insights into ATP5C1's biology and its roles in cellular homeostasis and disease .
When investigating ATP5C1's role in disease models, researchers should implement a systematic experimental approach:
Model Selection:
Choose disease-relevant cell types (e.g., neurons for neurodegenerative disorders)
Consider patient-derived samples when available
Develop appropriate in vivo models
Experimental Design Structure:
ATP5C1 Manipulation Strategies:
Approach | Methodology | Application |
---|---|---|
Genetic Modulation | CRISPR/Cas9 knockout or knockin | Create complete loss-of-function or point mutations |
siRNA/shRNA knockdown | Achieve temporary reduction in expression | |
Inducible expression systems | Control timing and level of expression | |
Functional Modulation | RNA-binding deficient mutants | Specifically target RNA-binding function |
MTS modifications | Alter mitochondrial import efficiency | |
Small molecule modulators | Target ATP5C1 or its RNA interactions |
Comprehensive Assessment:
Measure mitochondrial function (respirometry, membrane potential)
Assess ATP production capacity
Evaluate cellular stress responses
Monitor disease-relevant phenotypes
Compare RNA-binding patterns between disease and control samples
Data Analysis:
Apply appropriate statistical tests based on experimental design
Control for multiple comparisons
Consider repeated measures designs for time-course experiments
Use multivariate analysis to integrate multiple parameters
By following rigorous experimental design principles and incorporating appropriate controls , researchers can generate reliable insights into ATP5C1's role in disease pathogenesis, potentially identifying new therapeutic targets.
ATP synthase is a crucial enzyme found in the mitochondria, responsible for the synthesis of adenosine triphosphate (ATP), the primary energy carrier in cells. The enzyme operates by utilizing an electrochemical gradient of protons across the inner mitochondrial membrane during oxidative phosphorylation .
ATP synthase is composed of two linked multi-subunit complexes: the soluble catalytic core, F1, and the membrane-spanning component, Fo, which comprises the proton channel . The catalytic portion of mitochondrial ATP synthase consists of five different subunits: alpha, beta, gamma, delta, and epsilon. These subunits are assembled with a stoichiometry of three alpha, three beta, and a single representative of the other three .
The gamma subunit, encoded by the ATP5C1 gene, plays a pivotal role in the catalytic core of ATP synthase. It is involved in the rotational mechanism that drives ATP synthesis . The gamma subunit interacts with the alpha and beta subunits, facilitating the conformational changes necessary for ATP production .
The human recombinant ATP synthase gamma chain is typically produced in Escherichia coli (E. coli) expression systems. The recombinant protein is often fused to a His-tag at the N-terminus to facilitate purification through affinity chromatography . The purified protein is used in various research applications, including structural and functional studies of ATP synthase .